SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
PureTech Health plc (PTCHF) trades at a trailing P/E of 0.9, forward P/E of 4.4. Trailing earnings yield is 111.11%, forward earnings yield 22.68%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.9); earnings yield beats bond yields (111.11%).
- Trailing Earnings Yield 111.11% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PTCHF
Valuation Multiples
P/E (TTM)0.9
Forward P/E4.4
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio11.25
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.00
Forward EPS (Est.)$0.41
Book Value / Share$0.00
Revenue / Share$0.16
FCF / Share$0.00
Yields & Fair Value
Earnings Yield111.11%
Forward Earnings Yield22.68%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-2.10 |
$11.74M |
$-39.39M |
-335.5% |
| 2016 |
$-2.10 |
$4.43M |
$-48.79M |
-1101.2% |
| 2017 |
$1.10 |
$650K |
$30.87M |
4749.1% |
| 2018 |
$-1.60 |
$16.37M |
$-43.65M |
-266.7% |
| 2019 |
$14.40 |
$8.69M |
$421.14M |
4847.4% |
| 2020 |
$0.20 |
$8.34M |
$4.57M |
54.8% |
| 2021 |
$-2.10 |
$9.98M |
$-62.71M |
-628.4% |
| 2022 |
$-1.80 |
$2.09M |
$-37.06M |
-1773.4% |
| 2023 |
$-2.40 |
$3.33M |
$-65.7M |
-1972.9% |
| 2024 |
$2.00 |
$4.32M |
$53.51M |
1240.1% |
